VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 87 filers reported holding VAXCYTE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123,253 | +12.6% | 2,417,652 | +10.3% | 0.02% | +20.0% |
| Q2 2023 | $109,489 | +9016.5% | 2,192,382 | +6745.2% | 0.02% | – |
| Q1 2023 | $1,201 | -17.2% | 32,028 | +5.8% | 0.00% | – |
| Q4 2022 | $1,451 | -99.3% | 30,268 | +254.0% | 0.00% | – |
| Q3 2022 | $206,000 | -32.0% | 8,551 | -38.6% | 0.00% | – |
| Q2 2022 | $303,000 | -1.3% | 13,928 | +9.6% | 0.00% | – |
| Q1 2022 | $307,000 | +11.2% | 12,708 | +9.7% | 0.00% | – |
| Q4 2021 | $276,000 | -12.1% | 11,581 | -6.5% | 0.00% | – |
| Q3 2021 | $314,000 | +34.8% | 12,381 | +19.8% | 0.00% | – |
| Q2 2021 | $233,000 | – | 10,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $82,124,000 | 28.36% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $37,277,000 | 21.71% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,405,421 | $27,757,000 | 8.90% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $45,614,000 | 3.66% |
| RA Capital Management | 3,865,808 | $76,350,000 | 1.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 4,558,475 | $90,030,000 | 1.05% |
| Soleus Capital Management, L.P. | 293,650 | $5,800,000 | 1.04% |
| Opaleye Management Inc. | 357,800 | $7,067,000 | 1.04% |
| SABBY MANAGEMENT, LLC | 178,992 | $3,535,000 | 0.69% |
| Penn Mutual Asset Management, LLC | 22,227 | $439,000 | 0.50% |